Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03589469 |
|---|---|
| Brief Title: | Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (LOTIS-2) |
| First Submitted : | May 4, 2018 |
| First Submitted that Met QC Criteria : | July 5, 2018 |
| First Posted : | July 18, 2018 |
| Results First Submitted : | May 20, 2021 |
| Results First Posted with QC Comments : | June 18, 2021 |
| Results First Submitted that Met QC Criteria : | July 9, 2021 |
| Results First Posted : | July 29, 2021 |
| Last Update Submitted that Met QC Criteria : | August 3, 2023 |
| Last Update Posted : | August 29, 2023 |